MM

Megan Maloney

Managing Partner at Dria Ventures

United States

Overview 

Megan Maloney is the Founder & Managing Partner at Dria Ventures, with a background that includes roles at General Catalyst and Morgan Stanley. She has experience as an angel investor and has served as a board observer for companies like Audius and Grammarly. Maloney has a Master of Business Administration from Harvard Business School and has invested in a range of sectors such as Consumer Internet, Enterprise, and Female Investors.

Work Experience 

  • Founder & Managing Partner

    2024 - Current

  • Angel Investor

    2022

    I enjoy backing people w/ domain expertise & something to prove. My investments include: Garage (fire equipment, https://www.withgarage.com/) Givers (caregiving, https://www.joingivers.com/) Poolit (finance, https://www.poolit.com/) Lime Therapeutics (drug discovery, https://www.limetherapeutics.com/) Olukun Minerals (climate tech, https://www.olokunminerals.com/) Seven Starling (women's health, https://www.sevenstarling.com/)

  • Seed Investor

    2020 - 2021

    Head of Boston pre-seed / seed investing at RDV.

  • Principal

    2019 - 2021

    Early stage focus on founders tackling messy industries. Humbled to be closely involved with Grammarly, Livongo, Stripe, Gusto, O(1) Labs, Audius, Coda, Color, Pulley, Samsara, Commure and more.

  • Associate

    2017 - 2019

General Catalyst partners with ambitious founders to drive resilience and applied AI from seed to growth.

  • Board Observer

    2018 - 2020

  • Board Observer

    2017 - 2020

Grammarly is the trusted AI assistant for communication and productivity.

Raised $400,000,000.00 from Baillie Gifford and BlackRock.

  • Board Observer

    2017 - 2020

Samsara is digitizing the world of physical operations.

Raised $930,000,000.00 from Employee Stock Option Fund and Raison Wealth.

  • Board Observer

    2017 - 2020

Livongo provides a data science and technology enabled platform for detection of diabetes.

Raised $234,999,996.00 from Zaffre Investments, M12 - Microsoft's Venture Fund, Merck Global Health Innovation Fund, Kinnevik, Kleiner Perkins, General Catalyst, 7wire Ventures, Sapphire Ventures, Threshold and Echo Health Ventures.

  • Investment Banking Analyst, Technology

    2015 - 2017

  • Institutional Equity Analyst

    2013 - 2015

Morgan Stanley Venture Partners is a private equity firm that invests in high-growth companies in the technology and healthcare industries.

Articles About Megan

Relevant Websites